Report cover image

Negative Pressure Wound Therapy Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Product (Conventional NPWT, Single-use NPWT); By Wound Type (Burns and Surgical & Open Wounds, Pressure Ulcers, Diabetic

Publisher BlueWeave Consulting
Published Dec 12, 2022
Length 240 Pages
SKU # BLWC17630958

Description

Negative Pressure Wound Therapy Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Product (Conventional NPWT, Single-use NPWT); By Wound Type (Burns and Surgical & Open Wounds, Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Traumatic Wounds); By End User (Hospitals, Home Care Settings, Others); By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)

Global Negative Pressure Wound Therapy Market Size to Cross USD 4 Billion by 2028
Global negative pressure wound therapy market is flourishing owing to the increase in the frequency of chronic wounds, such as diabetic foot ulcers, post-surgical ulcers, and pressure ulcers, and increasing cost of wound care.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global negative pressure wound therapy market size at USD 2.25 billion in 2021. During the forecast period between 2022 and 2028, BlueWeave expects global negative pressure wound therapy market size to grow at a steady CAGR of 9.0% reaching a value of USD 4.08 billion by 2028. Due to the growing demand for advanced wound care, the market for negative pressure wound therapy is expected to expand (NPWT). Single-use NPWT devices are becoming more and more popular in the field of wound care management. For instance, Smith & Nephew unveiled PICO, a single-use NPWT that is now well-liked all over the world. It is expected that the industry demand will be significantly impacted by the rising prevalence of chronic diseases like diabetes. This is primarily because complications like diabetic foot ulcers are frequently caused by diabetes.
Global Negative Pressure Wound Therapy Market – Overview
Chronic wounds can result in complications, such as infection, ulceration, and insufficient blood supply, which lengthens the time it takes for a wound to heal. Vein ulcers, diabetic foot ulcers, and pressure ulcers are the three most prevalent chronic wounds. According to a National Institutes of Health (NIH) article in 2021, there were 64 million cases of diabetes in India, and 25% of those people had diabetic foot ulcers. According to a 2021 report from the Mission Regional Medical Center, there are currently 6.7 million people living with chronic wounds, and over the next ten years, that number is projected to increase by more than two percent. For the health care system, chronic wounds cost more than USD 50 billion.
More than 29 million Americans have diabetes, and nearly 2 million of them will develop a diabetic foot ulcer or another non-healing wound each year, according to the same source. Over the past 20 years, there has been a large body of research on the topical application of negative pressure wound therapy. Many clinical trials have demonstrated this therapy's efficacy in the management of superficial wounds. Additionally, the localized application of negative pressure wound therapy infected wounds has benefits including wound drainage, angiogenesis stimulation, proteinase excretion, and reduced local and systemic bacterial load. Negative Pressure Wound Therapy combined with silver dressings, as found in a study published in the International Wound Journal 2020, reduces infection. The market for negative pressure wound therapy is therefore expected to expand significantly throughout the forecast period because of the aforementioned factors.
Opportunity: Escalating demand for cutting-edge treatment methods
Increased awareness of technologically advanced treatment modalities is one of the main factors propelling growth in the global negative pressure wound therapy (NPWT) devices market. For instance, in December 2018, Kinetic Concepts, Inc. (KCI) unveiled the most recent development in negative pressure wound therapy that is specifically intended for multiple traumatic wounds. The V.A.C.RX4 Therapy System will soon be available in the US, according to KCI, an acceleration company. To help military personnel treat multiple battlefield wounds with a single negative pressure wound therapy (NPWT) device and to comply with safe-to-fly standards, the V.A.C.RX4 System was developed at the request of the US Air Force and Department of Defense.
Challenge: High cost of dressing replacement for wound therapy using negative pressure
The global negative pressure wound therapy market is dealing with several problems that are partially limiting its growth, despite maintaining a positive outlook. Some of these factors include the scarcity of trained professionals, the high price of advanced negative pressure wound therapy devices, and the growing acceptance of traditional wound management in developing countries.
Impact of COVID-19 on Global Negative Pressure Wound Therapy Market
The rapid spread of the COVID-19 virus caused a global pandemic that disrupted healthcare services, including the care of patients with wounds. Wound care delivery underwent a significant change due to the need, and it should be viewed as a fundamental clinical service. During the pandemic, the main objectives of negative pressure wound therapy shifted from ensuring that wounds fully healed to preventing serious complications to minimize the need for surgery and hospitalization. Major manufacturers' production has been drastically reduced because of the pandemic, which has increased the cost of wound dressings.
Global Negative Pressure Wound Therapy Market – By Wound Type
Negative pressure wound therapy is used to treat various types of wounds, including burns, surgical and open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatized wounds. In 2021, the market for negative pressure wound therapy (NPWT) devices was largely driven by the diabetic foot ulcer segment. Demand for negative-pressure wound therapy (NPWT) devices is anticipated to increase due to the rising incidence of diabetic foot ulcers. 15% of people with diabetes experience a diabetic foot ulcer, an open sore or wound on the bottom of the foot. Hospitalization for an infection or another issue related to the ulcer occurs in 6% of patients with foot ulcers.
Competitive Landscape
Global negative pressure wound therapy market is fiercely competitive. Prominent players in global negative pressure wound therapy market include Smith + Nephew, ConvaTec Group Plc, Cardinal Health, Paul Hartmann AG, Lohmann & Rauscher International GmbH & Co KG., Medela LLC, Alleva Medical Ltd., Cork Medical, Carilex Medical GmbH, Acelity L.P. Inc., Mölnlycke Healthcare AB, DeRoyal Industries, Inc, Genadyne Biotechnologies, Inc., Argentum Medical, LLC, and 4L Health Co. Ltd. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Negative pressure wound therapy Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Negative Pressure Wound Therapy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Negative Pressure Wound Therapy Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

240 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Negative Pressure Wound Therapy Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rise in prevalence of chronic & acute injuries
3.2.1.2. Better management of severe wound exudates
3.2.1.3. Reduction in overall treatment cost
3.2.2. Restraints
3.2.2.1. High costs of replacement of dressings for negative pressure wound therapy
3.2.3. Opportunities
3.2.3.1. Growing rate of hospitalization for acute and chronic injuries
3.2.3.2. Launch of technologically advanced NPWT devices
3.2.4. Challenges
3.2.4.1. Limited adoption of NPWT products
3.2.4.2. Limitations associated with negative pressure wound therapy
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Negative Pressure Wound Therapy Market Overview
4.1. Market Size & Forecast, 2018–2028
4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Conventional NPWT
4.2.1.2. Single-use NPWT
4.2.2. By Wound Type
4.2.2.1. Burns and Surgical & Open Wounds
4.2.2.2. Pressure Ulcers
4.2.2.3. Diabetic Foot Ulcers
4.2.2.4. Venous Leg Ulcers
4.2.2.5. Traumatic Wounds
4.2.3. By End User
4.2.3.1. Hospitals
4.2.3.2. Home Care Settings
4.2.3.3. Others
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. Europe
4.2.4.3. Asia Pacific (APAC)
4.2.4.4. Latin America
4.2.4.5. Middle East and Africa (MEA)
5. North America Negative Pressure Wound Therapy Market
5.1.1. Market Size & Forecast, 2018–2028
5.1.2. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Wound Type
5.2.3. By End User
5.2.4. By Country
5.2.4.1. United States
5.2.4.1.1. By Product
5.2.4.1.2. By Wound Type
5.2.4.1.3. By End User
5.2.4.2. Canada
5.2.4.2.1. By Product
5.2.4.2.2. By Wound Type
5.2.4.2.3. By End User
6. Europe Negative Pressure Wound Therapy Market
6.1. Market Size & Forecast, 2018–2028
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Wound Type
6.2.3. By End User
6.2.4. By Country
6.2.4.1. Germany
6.2.4.1.1. By Product
6.2.4.1.2. By Wound Type
6.2.4.1.3. By End User
6.2.4.2. United Kingdom
6.2.4.2.1. By Product
6.2.4.2.2. By Wound Type
6.2.4.2.3. By End User
6.2.4.3. Italy
6.2.4.3.1. By Product
6.2.4.3.2. By Wound Type
6.2.4.3.3. By End User
6.2.4.4. France
6.2.4.4.1. By Product
6.2.4.4.2. By Wound Type
6.2.4.4.3. By End User
6.2.4.5. Spain
6.2.4.5.1. By Product
6.2.4.5.2. By Wound Type
6.2.4.5.3. By End User
6.2.4.6. The Netherlands
6.2.4.6.1. By Product
6.2.4.6.2. By Wound Type
6.2.4.6.3. By End User
6.2.4.7. Belgium
6.2.4.7.1. By Product
6.2.4.7.2. By Wound Type
6.2.4.7.3. By End User
6.2.4.8. NORDIC Countries
6.2.4.8.1. By Product
6.2.4.8.2. By Wound Type
6.2.4.8.3. By End User
6.2.4.9. Rest of Europe
6.2.4.9.1. By Product
6.2.4.9.2. By Wound Type
6.2.4.9.3. By End User
7. Asia Pacific Negative Pressure Wound Therapy Market
7.1. Market Size & Forecast, 2018–2028
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Wound Type
7.2.3. By End User
7.2.4. By Country
7.2.4.1. China
7.2.4.1.1. By Product
7.2.4.1.2. By Wound Type
7.2.4.1.3. By End User
7.2.4.2. India
7.2.4.2.1. By Product
7.2.4.2.2. By Wound Type
7.2.4.2.3. By End User
7.2.4.3. Japan
7.2.4.3.1. By Product
7.2.4.3.2. By Wound Type
7.2.4.3.3. By End User
7.2.4.4. South Korea
7.2.4.4.1. By Product
7.2.4.4.2. By Wound Type
7.2.4.4.3. By End User
7.2.4.5. Australia & New Zealand
7.2.4.5.1. By Product
7.2.4.5.2. By Wound Type
7.2.4.5.3. By End User
7.2.4.6. Indonesia
7.2.4.6.1. By Product
7.2.4.6.2. By Wound Type
7.2.4.6.3. By End User
7.2.4.7. Malaysia
7.2.4.7.1. By Product
7.2.4.7.2. By Wound Type
7.2.4.7.3. By End User
7.2.4.8. Singapore
7.2.4.8.1. By Product
7.2.4.8.2. By Wound Type
7.2.4.8.3. By End User
7.2.4.9. Philippines
7.2.4.9.1. By Product
7.2.4.9.2. By Wound Type
7.2.4.9.3. By End User
7.2.4.10. Vietnam
7.2.4.10.1. By Product
7.2.4.10.2. By Wound Type
7.2.4.10.3. By End User
7.2.4.11. Rest of Asia Pacific
7.2.4.11.1. By Product
7.2.4.11.2. By Wound Type
7.2.4.11.3. By End User
8. Latin America Negative Pressure Wound Therapy Market
8.1. Market Size & Forecast, 2018–2028
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Wound Type
8.2.3. By End User
8.2.4. By Country
8.2.4.1. Brazil
8.2.4.1.1. By Product
8.2.4.1.2. By Wound Type
8.2.4.1.3. By End User
8.2.4.2. Mexico
8.2.4.2.1. By Product
8.2.4.2.2. By Wound Type
8.2.4.2.3. By End User
8.2.4.3. Argentina
8.2.4.3.1. By Product
8.2.4.3.2. By Wound Type
8.2.4.3.3. By End User
8.2.4.4. Peru
8.2.4.4.1. By Product
8.2.4.4.2. By Wound Type
8.2.4.4.3. By End User
8.2.4.5. Colombia
8.2.4.5.1. By Product
8.2.4.5.2. By Wound Type
8.2.4.5.3. By End User
8.2.4.6. Rest of Latin America
8.2.4.6.1. By Product
8.2.4.6.2. By Wound Type
8.2.4.6.3. By End User
9. Middle East & Africa Negative Pressure Wound Therapy Market
9.1. Market Size & Forecast, 2018–2028
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Wound Type
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Saudi Arabia
9.2.4.1.1. By Product
9.2.4.1.2. By Wound Type
9.2.4.1.3. By End User
9.2.4.2. UAE
9.2.4.2.1. By Product
9.2.4.2.2. By Wound Type
9.2.4.2.3. By End User
9.2.4.3. Qatar
9.2.4.3.1. By Product
9.2.4.3.2. By Wound Type
9.2.4.3.3. By End User
9.2.4.4. Kuwait
9.2.4.4.1. By Product
9.2.4.4.2. By Wound Type
9.2.4.4.3. By End User
9.2.4.5. Iran
9.2.4.5.1. By Product
9.2.4.5.2. By Wound Type
9.2.4.5.3. By End User
9.2.4.6. South Africa
9.2.4.6.1. By Product
9.2.4.6.2. By Wound Type
9.2.4.6.3. By End User
9.2.4.7. Nigeria
9.2.4.7.1. By Product
9.2.4.7.2. By Wound Type
9.2.4.7.3. By End User
9.2.4.8. Kenya
9.2.4.8.1. By Product
9.2.4.8.2. By Wound Type
9.2.4.8.3. By End User
9.2.4.9. Egypt
9.2.4.9.1. By Product
9.2.4.9.2. By Wound Type
9.2.4.9.3. By End User
9.2.4.10. Morocco
9.2.4.10.1. By Product
9.2.4.10.2. By Wound Type
9.2.4.10.3. By End User
9.2.4.11. Algeria
9.2.4.11.1. By Product
9.2.4.11.2. By Wound Type
9.2.4.11.3. By End User
9.2.4.12. Rest of Middle East & Africa
9.2.4.12.1. By Product
9.2.4.12.2. By Wound Type
9.2.4.12.3. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Negative Pressure Wound Therapy Company Market Share Analysis, 2021
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
11. Impact of Covid-19 on Global Negative Pressure Wound Therapy Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Smith + Nephew
12.2. ConvaTec Group Plc
12.3. Cardinal Health
12.4. Paul Hartmann AG
12.5. Lohmann & Rauscher International GmbH & Co KG.
12.6. Medela LLC
12.7. Alleva Medical Ltd.
12.8. Cork Medical
12.9. Carilex Medical GmbH
12.10. Acelity L.P. Inc.
12.11. Mölnlycke Healthcare AB
12.12. DeRoyal Industries, Inc
12.13. Genadyne Biotechnologies, Inc.
12.14. Argentum Medical, LLC
12.15. 4L Health Co. Ltd.
12.16. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us